20 articles
A molecular-level deep dive into AGE formation kinetics, RAGE isoforms, downstream transcriptional networks, and evidence-based interventions — for those who want the full mechanistic picture.
Go beyond the basics and explore the biochemical mechanisms behind glycation — from the Maillard reaction cascade to RAGE signaling and tissue cross-linking — to understand why AGEs are central to aging and metabolic disease.
Discover how sugar molecules quietly damage your proteins and cells over time — and what you can do to slow down this sneaky aging process.
Researchers analyzed 2,911 proteins in 50,506 people to create a frailty score that predicts disease risk and biological aging.
A 6-month AI-driven personalized diet intervention cut BMI by 33% and reduced biological age by 8 years in morbidly obese patients.
Second-generation epigenetic clocks show strong associations with metabolic syndrome and type 2 diabetes risk prediction.
A noninvasive 13-variable score reveals how fast your liver is aging — and accelerated liver aging raises mortality risk by up to 85%.
A completed trial investigates whether replenishing glutathione precursors can reverse metabolic dysfunction in elderly adults.
Large-scale study identifies three key blood proteins that predict diabetic retinopathy development with 90% accuracy.
New study shows DunedinPACE aging biomarker can predict who will develop metabolic syndrome years in advance, outperforming other epigenetic clocks.
Massive study reveals protein and metabolite signatures that could detect heart, kidney, eye and nerve damage before symptoms appear.
Large study reveals how gut microbe proteins shift with aging and contribute to diabetes and metabolic disorders.
Multi-omic analysis reveals GLP-1 receptor agonists counter aging processes across multiple organ systems and biological pathways.
Three NIH-funded studies this week tackle metabolic decline, cardiac risk, and brain tumors — all with aging implications.
Scientists identified 31 blood molecules that predict diabetes mortality risk, offering early warning signs for prevention.
Machine learning clusters CGM data into four distinct glycemic patterns, each linked to unique diabetic complication risks.
New composite biomarker combining inflammation, nutrition, and immunity markers shows promise for cardiovascular risk assessment.
Large NHANES study reveals metabolic syndrome causes measurable acceleration in epigenetic aging clocks, offering new targets for intervention.
New biomarker identifies who's at highest risk for diabetes, hypertension, and liver disease using simple blood test calculations.
Diabetes drugs like empagliflozin show surprising anti-aging effects — mimicking caloric restriction and reducing senescent cell burden.
